Wockhardt board to consider unaudited financial result

29 Jan 2014 Evaluate

Wockhardt has informed that a meeting of the Board of Directors of the Company will be held on February 09, 2014, inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2013 (Q3). Consideration of Interim Dividend.

The above information is a part of company’s filings submitted to BSE

 

Wockhardt Share Price

1298.95 -7.15 (-0.55%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×